The correlation between ACTN4 expression and tumour grade, tumour progression, and metastasis were reported for various human cancers, including osteosarcoma, melanoma, leukemia, prostate cancer, bladder cancer, lymphoma, pancreatic cancer, breast cancer, and gastric cancer [63,64]. This evidence concerns the gene ACTN4 and urinary bladder cancer.